Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |